Financhill
Back

RxSight 10K Form

Sell
30

RXST
RxSight

Last Price:
$13.30
Seasonality Move:
9.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RXST News And Ratings

See the #1 stock for the next 7 days that we like better than RXST

RXST Financial Statistics

Sales & Book Value

Annual Sales: $139.9M
Cash Flow: $-9.4M
Price / Cash Flow: 0
Annual Sales: $6.88
Price / Book: 1.93

Profitability

EPS (TTM): -0.67000
Net Income (TTM): $-26.5M
Gross Margin: $98.9M
Return on Equity: -10.39%
Return on Assets: -9.28%

RxSight Earnings Forecast

Key RxSight Financial Ratios

  • The Gross Profit Margin over the past 6 years for RXST is 70.71%.
  • The Selling, General & Administrative Expenses for RXST have been equal to 72.49% of Gross Profit Margin.
  • The Research & Development expenses have been 24.56% of Revenue.
  • The Net Earning history of RXST is -19.62% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

RxSight Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: RXST
Website: rxsight.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.68
Quick Ratio: 11.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 185.3

RXST Technical Analysis vs Fundamental Analysis

Sell
30
RxSight (RXST) is a Sell

Is RxSight a Buy or a Sell?

  • RxSight stock is rated a Sell
    The current RxSight [RXST] share price is $13.24. The Score for RXST is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.